Zentalis Pharmaceuticals’ $250 Million Underwritten Offering of Common Stock

Pietro Martinoia
Tagged:

Latham & Watkins represented Zentalis in the offering, and Cooley represented the underwriters.Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) announced the pricing of an underwritten offering of 11,032,656…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now